RxDoctor Payments Data

Joanne Hooks, APRN

Nurse Practitioner · Chatsworth, GANPI 1912903642

Payments from drug & device makers

$1,137in general payments, 2019–2025

Across 53 payments — averaging $21.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$210
  • Astellas Pharma US Inc$174
  • Teleflex LLC$124
  • Coloplast$123
  • AbbVie$92
  • Sumitomo Pharma America, Inc.$73
  • plus $342 from 12 others

What the payments were for

  • Food & beverage$1,04892%
  • Education$898%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,137 in reported general payments places this provider in the 75th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Medicare billing

Part B allowed, 2024
$52,508
Medicare patients
260
Services billed
1,648

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron136$118,565
MyrbetriqMirabegron72$58,182
Estradiol64$4,803
Tamsulosin Hcl328$3,553
Finasteride221$2,794
Methenamine Hippurate19$1,258
Fesoterodine Fumarate ErFesoterodine Fumarate13$1,048
Cefdinir87$1,015
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst69$945
Solifenacin Succinate27$903
Oxybutynin Chloride44$885
Alfuzosin Hcl ErAlfuzosin Hcl47$756
Doxycycline Hyclate65$668
Nystatin35$477
Metronidazole16$209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$73$118,565136 claims
Astellas Pharma US IncMyrbetriq$174$58,18272 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Chatsworth

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →